1 asset in Mevalonate Kinase Deficiency

Therapeutic assets addressing Mevalonate Kinase Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region) Mevalonate Kinase Deficiency	Novartis Pharmaceuticals	P2	CCC (54)